News and Trends 16 Feb 2023
Maxion Therapeutics raises $16M to target GPCRs
Biotechnology company Maxion Therapeutics has completed its $16 million Series A financing. The funds will be used to support the development of novel biologics targeting ion channels and G-protein-coupled receptors…